Oncotelic Therapeutics, Inc. (OTCQB: OTLC) announced the completion of key Phase 2 objectives in its manufacturing automation initiative with TechForce Robotics, advancing the commercialization of an AI-powered good manufacturing practices (GMP) manufacturing services platform at SAPU Bio, the company’s 45%-owned sterile injectable cGMP manufacturing joint venture. The Phase 2 deployment expands the capabilities of Oncotelic’s proprietary PDAOAI platform across sterile manufacturing operations, electronic batch records, GMP workflow execution, cleanroom monitoring and autonomous materials movement.
The integrated platform combines PDAOAI with TechForce’s autonomous robotic systems to support intelligent pharmaceutical manufacturing and create potential opportunities in software licensing, automation deployment, manufacturing partnerships and technology-enabled contract development and manufacturing services (CDMO). This development is significant as it positions Oncotelic to tap into the growing market for AI-driven pharmaceutical manufacturing, which promises to reduce costs, improve quality, and accelerate production timelines. The company plans to demonstrate the platform at the BIO International Convention 2026 in San Diego as it pursues broader commercialization efforts within the pharmaceutical manufacturing sector.
Oncotelic Therapeutics is a clinical-stage biopharmaceutical company focused on oncology and immunotherapy products, addressing high-unmet-need cancers and rare pediatric indications. The company’s CEO, Dr. Vuong Trieu, has filed over 500 patent applications and holds 75 issued patents, contributing to a robust portfolio of inventions. Beyond its internal pipeline, Oncotelic licenses and co-develops drug candidates through strategic partnerships and joint ventures. The completion of this Phase 2 milestone underscores Oncotelic’s commitment to leveraging artificial intelligence to enhance its manufacturing capabilities and create value for stakeholders.
For more information, see the full press release at https://nnw.fm/j1n43.
